<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00451984</url>
  </required_header>
  <id_info>
    <org_study_id>VN2005/32</org_study_id>
    <nct_id>NCT00451984</nct_id>
  </id_info>
  <brief_title>Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2</brief_title>
  <acronym>HEPVACHIV</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Aalborg Universitetshospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aalborg Universitetshospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The response to vaccination for hepatitis is reduced in patients with HIV infection. The
      hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the
      time of vaccination improves the response rate.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2007</start_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antibody response to hepatitis A and hepatitis B</measure>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>HIV Infections</condition>
  <condition>Hepatitis A</condition>
  <condition>Hepatitis B</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Twinrix</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>interleukin-2</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults with stable antiretroviral therapy and negative for hepatitis A or B

        Exclusion Criteria:

          -  Prior hepatitis A or B
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Henrik Nielsen, MD, DMSci</last_name>
    <role>Study Chair</role>
    <affiliation>Aalborg Hospital, DK-9000 Aalborg, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Henrik Nielsen, MD, DMSci</last_name>
    <phone>+45-99326525</phone>
    <email>henrik.nielsen@rn.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Infectious Diseases, Aalborg Hospital</name>
      <address>
        <city>Aalborg</city>
        <zip>DK9000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Raquel M Iguacel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Henrik Nielsen, MD, DMSci</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Infectious Diseases, Skejby Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>DK8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alex Laursen, MD, DMSci</last_name>
      <phone>+45-89495566</phone>
    </contact>
    <investigator>
      <last_name>Ole SÃ¸gaard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2007</study_first_submitted>
  <study_first_submitted_qc>March 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 26, 2007</study_first_posted>
  <last_update_submitted>October 31, 2007</last_update_submitted>
  <last_update_submitted_qc>October 31, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2007</last_update_posted>
  <keyword>interleukin-2</keyword>
  <keyword>vaccination</keyword>
  <keyword>treatment experienced</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Interleukin-2</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

